Samsung Bioepis Presents Phase 1 Study Results of SB17 (Ustekinumab), A Proposed…
<!-- Name:DistributionId Value:8789635 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Stelara
EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara®…
<!-- Name:DistributionId Value:1000781638 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for…
The U.S. Food and Drug Administration’s (FDA) regulatory review is anticipated to be completed in the second half of 2023Stelara® (ustekinumab) is prescribed to treat a variety of…
An Intestinal Transplant First; 4-Year Stelara Data in UC; Lymphoma After Anti-TNF
A 1-year-old girl from Spain is the world's first successful recipient of a multi-visceral…
FDA Clears AI Polyp Detection Device; IBD and Sexual Issues; Stelara in Pregnancy
The FDA cleared the artificial intelligence-assisted Skout polyp detection device for adults…